Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain
NCT ID: NCT05771103
Last Updated: 2023-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2023-01-01
2023-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Group B: Thermal RF; thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome
NCT06033456
Radiofrequency for Chronic Post-mastectomy Pain: is it Better to Target Intercostal Nerves or Corresponding Dorsal Root Ganglia?
NCT03374423
Post Mastectomy Pain Syndrome After Preoperative Stellate Ganglion Block for Breast Cancer Surgeries
NCT04238377
Extracorporeal Shock Wave Therapy on Neuropathic Pain Post Mastectomy
NCT06452615
Shoulder Denervation for Post Mastectomy Irradiation Shoulder Pain
NCT07095569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Complex regional pain syndrome (CRPS) is a clinical diagnosis with a highly variable presentation and prognosis. CRPS type I, previously known as reflex sympathetic dystrophy (RSD), is not associated with direct nerve injury. CRPS type II, or causalgia, is associated with direct injury of a specific nerve often from surgical intervention or trauma.
The stellate ganglion (SG), also known as the cervico-thoracic ganglion, is part of the sympathetic nervous system.
After assessment of eligibility criteria a predetermined randomization list and will be generated using random blocks.
* Group A: SGB with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy.
* Group B: Thermal RF; thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice has to be 0.5 cm apart from each other . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance
* Group A ,The procedure will be started by placing the needle tip аntеrоlаteral to the lоngusсоlli muscle, dееp to the prеvеrtebrаlfаsсia in оrdеr tо аvоid spread along the carotid sheath, but superficial to the fascia investing the longus colli muscle (to prevent injecting into the muscle). Identifying the correct fascial plane achieved with portable ultrasound guidance thus facilitating the caudal spread of the injectate to reach the stellate ganglion at the C7-T1 level. This allowed for a more effective and stable sympathetic block with the use of a small injected volume. As an injection, we firstly used 1%-2.0 ml of lidocaine. The procedure will be continued by the injection of ethanol 50%, in quantity 1.5 ml for a lasting effect.
* Group B, thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stellate ganglion block with alcohol injection
Stellate ganglion block with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy.
thermal Radiofrequency neurolysis of Stellate ganglion
Stellate ganglion block with alcohol injection versus thermal RF neurolysis of Stellate ganglion
thermal RF neurolysis of Stellate ganglion
Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance
thermal Radiofrequency neurolysis of Stellate ganglion
Stellate ganglion block with alcohol injection versus thermal RF neurolysis of Stellate ganglion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
thermal Radiofrequency neurolysis of Stellate ganglion
Stellate ganglion block with alcohol injection versus thermal RF neurolysis of Stellate ganglion
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pain duration of more than 6 months
* Pain is moderate to severe pain (visual analog scale \[VAS\] ≥ 4 cm),
* Pain described as a refractory one that is defined as pain for which classic biomedical therapy has proven ineffective
* Pain is of positive neuropathic character as detected by the grading system for neuropathic pain (GSNP), with a score of 3 or 4
Exclusion Criteria
* Recent myocardial infarction
* Anti-coagulated patients or coagulopathy (evaluate risk/benefit ratio)
* Glaucoma
* Pre-existing counter lateral nerve palsy
* Severe emphysema
* Cardiac conduction block
* Local and systemic sepsis
* Local anatomical distortion (which may render the block technically difficult or hazardous.
* Psychiatric illness.
20 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
suzan adlan, lecturer
Role: PRINCIPAL_INVESTIGATOR
National Cancer Institute, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NCIEgypt IRB office
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP2212-501-027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.